PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY

被引:0
作者
Baldini, Capucine [1 ]
Cassier, Philippe A. [2 ]
Delord, Jean-Pierre [3 ]
Simonelli, Matteo [4 ]
Touat, Mehdi [5 ]
Yao, Lili [6 ]
Duic, J. Paul [6 ]
Gozman, Alexander [6 ]
Marabelle, Aurelien [7 ,8 ]
机构
[1] Univ Paris Saclay, Drug Dev Dept DITEP, Gustave Roussy, Villejuif, France
[2] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[3] Inst Claudius Regaud IUCT Oncopole, Toulouse, France
[4] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy
[5] Humanitas Res Hosp, IRCCS, Rozzano, Italy
[6] Sorbonne Univ, AP HP, Univ Pitie Salpetriere Charles Foix,CNRS, Inst Cerveau,ICM,Serv Neurol, 2 Mazarin, F-75013 Paris, France
[7] Merck Co Inc, Rahway, NJ USA
[8] Univ Paris Saclay, Inst Natl Sante & Rech Med, Dept Innovat Therapeut & Essais Precoces, Gustave Roussy,U1015 CIC1428, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CTIM-03
引用
收藏
页码:59 / 60
页数:2
相关论文
empty
未找到相关数据